31 Drugs Facing FDA Approval in 2012-2013
BOSTON (TheStreet) -- Here's an updated list of biotech and pharmaceutical companies with pending FDA drug approval decisions for the rest of 2012 and into early 2013. This refresh includes changes and additions to the FDA calendar last published at the end of July.
The calendar on the following pages captures the most important U.S. regulatory events -- FDA drug approvals and advisory panels -- expected between August and March 2013. As every savvy biotech investor and trader knows, the volatility in biotech and drug stocks ramps significantly as U.S. regulators weigh whether to approve or reject new drugs.
Biotech and drug stocks below are listed in chronological order based on the closest regulatory catalyst. ...Click to view a price quote on NAVB. Click to research the Health Services industry.
Original Article: 31 Drugs Facing FDA Approval in 2012-2013NEXT ARTICLE